Advertisement

Sepsis and Multiple Organ Failure

  • Jean-Charles PreiserEmail author
  • Vincent Fraipont
Chapter

Abstract

Signs of sepsis are systematically present in each critically ill patient after a few days of stay in an intensive care unit.The associated metabolic response includes a rise in expended energy a few after its onset and changes in the use of energy substrates. General recommendations include the preference of the oral or enteral route and a limitation of the caloric intake during the early phase. Nutritional interventions have been assessed to modulate the inflammatory response underlying the metabolic changes, including the addition of supplemental omega-3 fatty acids, glutamine and antioxidants. The beneficial effects of these interventions started during the course of critical illness have not been convincingly confirmed. Hence, no specific diet or nutritional formula is currently recommended.

Keywords

Severe Sepsis Septic Patient Nutritional Intervention Energy Substrate Glutathione Peroxidase Enzyme 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Kreymann G, Grosser S, Buggisch P, Gottschall C, Matthaei S, Greten H (1993) Oxygen consumption and resting metabolic rate in sepsis, sepsis syndrome, and septic shock. Crit Care Med 21:1012–1019CrossRefPubMedGoogle Scholar
  2. 2.
    Plank LD, Connolly AB, Hill GL (1998) Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis. Ann Surg 228:146–158CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Soeters MR, Soeters PB (2012) The evolutionary benefit of insulin resistance. Clin Nutr 31:1002–1007CrossRefPubMedGoogle Scholar
  4. 4.
    Lena D, Kalfon P, Preiser JC, Ichai C (2011) Glycemic control in the intensive care unit and during the postoperative period. Anesthesiology 114:438–444CrossRefPubMedGoogle Scholar
  5. 5.
    Tappy L, Chiolero R (2007) Substrate utilization in sepsis and multiple organ failure. Crit Care Med 35:S531–S534CrossRefPubMedGoogle Scholar
  6. 6.
    Preiser JC, Ichai C, Orban JC, Groeneveld AB (2014) Metabolic response to the stress of critical illness. Br J Anaesth 113:945–954CrossRefPubMedGoogle Scholar
  7. 7.
    Shaw JH, Klein S, Wolfe RR (1985) Assessment of alanine, urea, and glucose interrelationships in normal subjects and in patients with sepsis with stable isotopic tracers. Surgery 97:557–568PubMedGoogle Scholar
  8. 8.
    Dungan KM, Braithwaite SS, Preiser JC (2009) Stress hyperglycaemia. Lancet 373:1798–1807CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Mesotten D, Preiser JC, Kosiborod M (2015) Glucose management in critically ill adults and children. Lancet Diabetes Endocrinol 3:723–733CrossRefPubMedGoogle Scholar
  10. 10.
    Druml W, Fischer M, Ratheiser K (1998) Use of intravenous lipids in critically ill patients with sepsis without and with hepatic failure. JPEN J Parenter Enteral Nutr 22:217–223CrossRefPubMedGoogle Scholar
  11. 11.
    Siegel JH, Vary TC, Rivkind A, Bilik R, Coleman B, Tall BE, Morris JG (1989) Abnormal metabolic control in the septic multiple organ failure syndrome: pharmacotherapy for altered fuel control mechanisms. Prog Clin Biol Res 308:535–543PubMedGoogle Scholar
  12. 12.
    Weijs PJM, Cynober L, Delegge M, Kreyman G, Wernerman J, Wolfe RR (2014) Proteins and amino acids are fundamental to optimal nutrition support in critically ill patients. Crit Care 18:591CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Goulet O, Antebi H, Wolf C, Talbotec C, Alcindor LG, Corriol O, Lamor M, Colomb-Jung V (2010) A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr 34:485–495CrossRefPubMedGoogle Scholar
  14. 14.
    Han YY, Lai SL, Ko WJ, Chou CH, Lai HS (2012) Effects of fish oil on inflammatory modulation in surgical intensive care unit patients. Nutr Clin Pract 27:91–98CrossRefPubMedGoogle Scholar
  15. 15.
    Mayer K, Schaefer MB, Seeger W (2006) Fish oil in the critically ill: from experimental to clinical data. Curr Opin Clin Nutr Metab Care 9:140–148CrossRefPubMedGoogle Scholar
  16. 16.
    Michaeli B, Berger MM, Revelly JP, Tappy L, Chiolero R (2007) Effects of fish oil on the neuro-endocrine responses to an endotoxin challenge in healthy volunteers. Clin Nutr 26:70–77CrossRefPubMedGoogle Scholar
  17. 17.
    Barbosa VM, Miles EA, Calhau C, Lafuente E, Calder PC (2010) Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care 14:R5CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Edmunds CE, Brody RA, Parrott JS, Stankorb SM, Heyland DK (2014) The effects of different IV Fat emulsions on clinical outcomes in critically ill patients*. Crit Care Med 42:1168–1177CrossRefPubMedGoogle Scholar
  19. 19.
    Friesecke S, Lotze C, Köhler J, Heinrich A, Felix SB, Abel P (2008) Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomised controlled trial. Intensive Care Med 34:1411–1420CrossRefPubMedGoogle Scholar
  20. 20.
    Grau-Carmona T, Bonet-Saris A, García-de-Lorenzo A et al (2015) Influence of n-3 polyunsaturated fatty acids enriched lipid emulsions on nosocomial infections and clinical outcomes in critically ill patients: ICU lipids study. Crit Care Med 43:31–39CrossRefPubMedGoogle Scholar
  21. 21.
    Jurewitsch B (2012) The evolving utility and emergent uses of novel lipid emulsions: new horizons and rediscovered prospects. JPEN J Parenter Enteral Nutr 36:626–629CrossRefPubMedGoogle Scholar
  22. 22.
    Pontes-Arruda A, Martins LF, de Lima SM, Isola AM, Toledo D, Rezende E, Maia M, Magnan GB, GLA & Antioxidants Role in Sepsis Treatment Study G. II (2011) Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter, prospective, randomized, double blinded and controlled Study – INTERSEPT study. Crit Care 15:R144CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Santacruz CA, Orbegozo D, Vincent JL, Preiser JC (2015) Modulation of dietary lipid composition during acute respiratory distress syndrome: systematic review and meta-analysis. JPEN J Parenter Enteral Nutr 39(7):837–846CrossRefPubMedGoogle Scholar
  24. 24.
    Marimuthu K, Varadhan KK, Ljungqvist O (2012) Lobo DN.A meta-analysis of the effect of combinations of immune modulating nutrients on outcome in patients undergoing major open gastrointestinal surgery. Ann Surg 255:1060–1068CrossRefPubMedGoogle Scholar
  25. 25.
    Cynober L, De Bandt JP (2014) Glutamine in the intensive care unit. Curr Opin Clin Nutr Metab Care 17:98–104PubMedGoogle Scholar
  26. 26.
    Oudemans-van Straaten HM, van Zanten AR (2014) Glutamine supplementation in the critically ill: friend or foe? Crit Care 18:143CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Dechelotte P, Hasselmann M, Cynober L et al (2006) L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med 34:598–604CrossRefPubMedGoogle Scholar
  28. 28.
    Goeters C, Wenn A, Mertes N, Wempe C, Van Aken H, Stehle P, Bone HG (2002) Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med 30:2032–2037CrossRefPubMedGoogle Scholar
  29. 29.
    Griffiths RD, Allen KD, Andrews FJ, Jones C (2002) Infection, multiple organ failure, and survival in the intensive care unit: influence of glutamine-supplemented parenteral nutrition on acquired infection. Nutrition 18:546–552CrossRefPubMedGoogle Scholar
  30. 30.
    Andrews PJ, Avenell A, Noble DW, Campbell MK, Croal BL, Simpson WG, Vale LD, Battison CG, Jenkinson DJ, Cook JA (2011) Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ 342:d1542CrossRefPubMedGoogle Scholar
  31. 31.
    Heyland D, Muscedere J, Wischmeyer PE, Cook D, Jones G, Albert M, Elke G, Berger MM, Day AG (2013) A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 368:1489–1497CrossRefPubMedGoogle Scholar
  32. 32.
    van Zanten AR, Sztark F, Kaisers UX, Zielmann S, Felbinger TW, Sablotzki AR, De Waele JJ, Timsit JF, Honing ML, Keh D, Vincent JL, Zazzo JF, Fijn HB, Petit L, Preiser JC, van Horssen PJ, Hofman Z (2014) High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial. JAMA 312:514–524CrossRefPubMedGoogle Scholar
  33. 33.
    Motoyama T, Okamoto K, Kukita I, Hamaguchi M, Kinoshita Y, Ogawa H (2003) Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 31:1048–1052CrossRefPubMedGoogle Scholar
  34. 34.
    Preiser JC (2012) Oxidative stress. JPEN J Parenter Enteral Nutr 36:147–154CrossRefPubMedGoogle Scholar
  35. 35.
    Manzanares W, Langlois PL, Hardy G (2013) Update on antioxidant micronutrients in the critically ill. Curr Opin Clin Nutr Metab Care 16:719–725CrossRefPubMedGoogle Scholar
  36. 36.
    Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39:165–228CrossRefPubMedGoogle Scholar
  37. 37.
    Preiser J-C, van Zanten ARH, Berger MM et al (2015) Metabolic and nutritional support of critically ill patients: consensus and controversies. Crit Care 19:309CrossRefGoogle Scholar
  38. 38.
    Lefrant JY, Hurel D, Cano NJ, Ichai C, Preiser JC, Tamion F (2014) Guidelines for nutrition support in critically ill patient. Ann Fr Anesth Reanim 33:202–218CrossRefPubMedGoogle Scholar
  39. 39.
    Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, Forbes A, Griffiths R, Kreyman G, Leverve X, Pichard C (2009) ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr 28:387–400CrossRefPubMedGoogle Scholar
  40. 40.
    Wernerman J, Kirketeig T, Andersson B et al (2011) Scandinavian glutamine trial: a pragmatic multi-centre randomised clinical trial of intensive care unit patients. Acta Anaesthesiol Scand 55:812–818CrossRefPubMedGoogle Scholar
  41. 41.
    Grau T, Bonet A, Miñambres E et al (2011) The effect of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients. Crit Care Med 39:1263–1268CrossRefPubMedGoogle Scholar
  42. 42.
    Valenta J, Brodska H, Drabek T, Hendl J, Kazda A (2011) High-dose selenium substitution in sepsis: a prospective randomized clinical trial. Intensive Care Med 37:808–815CrossRefPubMedGoogle Scholar
  43. 43.
    Grau-Carmona T, Morán-García V, García-de-Lorenzo A et al (2011) Effect of an enteral diet enriched with eicosapentaenoic acid, gamma-linolenic acid and anti-oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clin Nutr 30:578–584CrossRefPubMedGoogle Scholar
  44. 44.
    Stapleton RD, Martin TR, Weiss NS et al (2011) A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med 39:1655–1662CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Rice TW, Wheeler AP, Thompson BT, de Boisblanc BP, Steingrub J, Rock P, NIH NHLBI Acute Respiratory Distress Syndrome Network of Investigators (2011) Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA 306:1574–1581CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Kagan I, Cohen J, Stein M et al (2015) Preemptive enteral nutrition enriched with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in severe multiple trauma: a prospective, randomized, double-blind study. Intensive Care Med 41:460–469CrossRefPubMedGoogle Scholar
  47. 47.
    Hall TC, Bilku DK, Al-Leswas D et al (2015) A randomized controlled trial investigating the effects of parenteral fish oil on survival outcomes in critically ill patients with sepsis: a pilot study. JPEN J Parenter Enteral Nutr 39:301–312CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of Intensive CareErasme University Hospital, Free University of BrusselsBrusselsBelgium
  2. 2.Intensive CareCentre hospitalier regional La CitadelleLiegeBelgium

Personalised recommendations